市场调查报告书
商品编码
1218858
全球安瓿包装市场:预测至2028年-按材料(玻璃、塑料、金属),体积(<2ml,3-5ml,6-8ml,8ml等),类型,应用,用户,地区Ampoules Packaging Market Forecasts to 2028 - Global Analysis By Material Type (Glass, Plastic and Metal), By Capacity (Less than 2 ml, 3 to 5 ml, 6 to 8 ml and Above 8 ml), By Ampoule Type, By Application, By End User and By Geography |
根据 Stratistics MRC 的数据,2022 年全球安瓶包装市场规模将达到 45 亿美元,预计到 2028 年将达到 77 亿美元,预测期内復合年增长率为 9.4%。
注射剂使用安瓿包装。 是用来防止液体和固体污染的小瓶子。 由玻璃或塑料製成的安瓿可保持药物无菌并防止其受到污染。 病毒感染和疾病的增加增加了对药物和疫苗的市场需求。 该市场还受益于药品包装安全法规的收紧。
据 Pharphorum 称,拉丁美洲的老年人口增长迅速。 2010 年,该地区 10% 的人口年龄在 60 岁以上,到 2040 年底,这一数字估计将翻一倍以上,达到 21%。
市场动态
促进因素
产品包装需求
製药行业对安瓿瓶的需求显着增加。 药物使用量的增长受到诸如防潮层、高尺寸稳定性、高衝击强度、抗应变性、最小吸水性、透明度、耐热性和阻燃性以及延长保质期等因素的推动。此外,对负担得起的包装的需求不断增长也对市场扩张做出了重大贡献。
抑制因素
严格的政府监管
严格的政府法规促使製造商提供安全包装并刺激市场扩张。 但是,破裂、破损或受污染的玻璃安瓿可能会导致经皮损伤。 预计这将对预测期内玻璃安瓿包装的增长构成挑战。
机会
技术进步
发达国家和发展中国家的政府、联合采购组织、监管和咨询小组一直在努力推动推动全球疫苗需求的关键参与者。 这可能会导致安瓿产能很快增加。 包装技术的进步使安瓿经久耐用、具有成本效益且与内容物无关。 因此,安瓿更常用于储存各种商品,尤其是液体样品。
威胁
不断上升的製造成本和玻璃的脆弱性
由于安瓿只能使用一次,因此回收是一个非常重要的过程,跳过这个过程会大大增加製造成本。 此外,玻璃安瓿的内容物可能会受到污染。 因此,在预测期内,玻璃安瓿市场将受到阻碍。 此外,限制玻璃安瓿市场增长的主要问题是玻璃易碎。 但是,塑料安瓶也存在吸水性高、耐热性差等缺点。
COVID-19 的影响
全球包装安瓿市场受到了 COVID-19 的负面影响。 供应链中断,生产中断。 因此,市场增长显着放缓。 另一方面,在此期间对药品的需求显着增长。 由于对安瓿和药品的需求相关,市场呈现 V 型复苏。 展望未来,全球市场有望恢復到之前的增长速度。
医药板块有望成为预测期内最大的板块
在最终用户中,预计医药领域将在预测期内主导市场。 随着人口中疾病爆发的增加,市场正在扩大。 必须使用安瓿来保持药品的无菌状态。 此外,环保且价格低廉的包装材料的发展,也让药用安瓿更加实用。
预计塑料行业在预测期内復合年增长率最高
在製药行业,塑料安瓿瓶的需求量大幅增加。 因此,预计塑料行业在预测期内将实现有利可图的增长。 防潮性、高尺寸稳定性、高衝击强度、抗应变性、低吸水性、透明性、耐热性、阻燃性和延长的保质期是推动这种增长的一些因素。 另一个重要因素是对低成本包装材料的高需求。
市场份额最高的地区
在预测期内,由于美国健康相关感染和过敏症的增加导致药物和疫苗数量增加,预计北美将主导全球安瓿市场。 此外,拉丁美洲国家正在积极尝试将这些假冒药品、疫苗和药物置于消费者接触不到的地方,这对市场增长产生了负面影响。
复合年增长率最高的地区
SGD Pharma India Ltd. 等一些公司每年生产 4,000 吨管状西林瓶和安瓿瓶(相当于 SGD Pharma(印度)Vemula 玻璃厂生产 7 亿多吨)。
主要发展
2021年8月,最大的疫苗和生物製品生产商印度血清研究所收购了印度包装合资企业肖特凯莎50%的股权。 德国特种玻璃公司 SCHOTT AG 和印度集团 Kaisha 的合资企业生产药品包装产品,例如用于包装救生药物的西林瓶、注射器、安瓿和药筒。
2021 年 5 月,日本包装公司 Nipro Pharma Packaging 收购了克罗地亚玻璃药品包装製造商 Piramida。 在蓝海资本私募股权基金的入股下,Piramida 进行了设施现代化改造,新增了 8 条生产线,安瓶和西林瓶业务得到了强劲发展。 因此,该公司跻身欧洲市场前五名製药安瓿製造商之列。
2021 年 3 月,製药和医疗保健行业的开发服务提供商 Aenova 显着提高了格罗瑙工厂的安瓿瓶产能。 一条新的安瓿瓶灌装和封口线、格罗瑙工厂的第六条无菌线、一条全新的全自动光学控制线以及一条新的包装线使每年生产超过 1 亿个安瓿瓶和西林瓶成为可能。
本报告的内容
免费定制服务
订阅此报告的客户将免费获得以下自定义选项之一
根据产品组合、地理分布和战略联盟对主要参与者进行基准测试
According to Stratistics MRC, the Global Ampoules Packaging Market is accounted for $4.5 billion in 2022 and is expected to reach $7.7 billion by 2028 growing at a CAGR of 9.4% during the forecast period. Injectable medication is packaged in ampoules. They are small bottles that are used to prevent contamination of liquids and solids. Drugs are kept sterile and protected from contamination by ampoules, which are either made of glass or plastic. Due to the rise in viral infections and diseases, there is a rising market demand for medications and vaccines. The market is also being driven by an increase in safety regulations for pharmaceutical packaging.
According to Pharmaphorum, Latin America's geriatric base is increasing rapidly. In 2010, 10% of the region's population was above 60 years, and by the end of 2040, this number is estimated to more than double, reaching 21%.
Market Dynamics:
Driver:
Demand for Product Packaging
The demand for ampoules in the pharmaceutical industry is rising significantly. The increased use of pharmaceuticals has been facilitated by factors such as moisture barriers, high dimensional stability, high impact strength, resistance to strain, minimal water absorption, transparency, heat and flame resistance, and extensions of expiration dates. Furthermore, contributing significantly to the market's expansion is the rising demand for affordable packaging.
Restraint:
Stringent government regulations
Because of the government's strict regulations, manufacturers provide safe packaging, which will spur market expansion. However, glass ampoules that are cracked, broken, or contaminated may cause percutaneous injury. This is expected to be a difficult task in the growth of glass ampoules packaging during the forecast period.
Opportunity:
Technological advancements
Governments in developed and developing nations, pooled procurement organisations, and regulatory and advisory cells made an effort for the advancements in the key players which is fueling the global demand for vaccines. This will likely lead to an increase in ampoule output capacity quickly. Due to advances in packaging technology, ampoules are now more durable, cost-effective, and content-independent. As a result, ampoules are used more commonly to store a variety of goods, especially liquid samples.
Threat:
Rise in production cost and brittleness of glass
Recycling is a crucial step because ampoules can only be used once, so skipping this step would result in a significant increase in production costs. It is still a concern that glass ampoules can contaminate the contents due to this. The market for glass ampoules is therefore hampered during the projection period. Additionally, a major issue limiting growth in the market for glass ampoules is the brittleness of glass. But plastic ampoules have drawbacks as well, including high absorbability and low heat resistance.
COVID-19 Impact:
The market for packaging ampoules around the world was negatively impacted by COVID-19. Production was interrupted as a result of extensive supply chain disruptions. The market growth rate significantly decreased as a result. On the other hand, the demand for pharmaceuticals rose sharply during that time. The market displayed a V-shaped recovery because the demand for ampoules and drugs are directly correlated. It is anticipated that the global market will soon return to its prior growth rate.
The Pharmaceutical segment is expected to be the largest during the forecast period
Among end users, the pharmaceuticals segment is expected to dominate the market during the projection period. The market is expanding as disease incidence among groups of people is increasing. Ampoules must be used in order to preserve the aseptic conditions of pharmaceutical drugs. Moreover, pharmaceutical ampoules are becoming more viable due to the development of environmentally friendly and affordable packaging materials.
The plastic segment is expected to have the highest CAGR during the forecast period
The pharmaceutical industry has seen a significant increase in the demand for plastic ampoules; therefore, the plastic segment is anticipated to have lucrative growth during the estimation period. Barriers against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, resistance to heat and flame, and extension of expiration dates are features that have contributed to this growth. Another important factor in this regard is the high demand for low-cost packaging.
Region with largest share:
Over the forecast period, North America is anticipated to dominate the global ampoules market as the number of drugs and vaccines has increased due to rising health-related infections and allergies in the United States. Furthermore, Latin American countries are actively working to prevent these counterfeit medicines, vaccines, and drugs from reaching consumers, which has an adverse effect on the market's growth.
Region with highest CAGR:
Asia Pacific region is expected to have lucrative growth during the forecast period as developing nations like India experience exceptional growth in the pharmaceutical industry, including players like SGD Pharma India Ltd., which produces 4,000 metric tonnes of tubular vials and ampoules annually (equivalent to more than 700 million pieces at the Vemula glassworks of SGD Pharma (India)).
Key players in the market
Some of the key players in Ampoules Packaging market include AAPL Solutions, Nipro Pharma Packaging International NV, Schott AG, Gerresheimer AG, J.Penner Corporation, Stevanato Group, ESSCO Glass, James Alexander Corporation, Amposan S.A., Global Pharmatech Pvt Ltd, Hindusthan National Glass & Industries Limited, Adelphi Healthcare Packaging, Solopharm Company and Sandfire Scientific Ltd.
Key Developments:
In August 2021, Serum Institute of India, the largest vaccine producer and manufacturer of biologics, had bought a 50% stake in the Indian packaging joint venture SCHOTT Kaisha. The joint venture between Germany's specialty glass company SCHOTT AG and Indian group Kaisha, manufactures pharma packaging products such as vials, syringes, ampoules and cartridges used to package life-saving medications.
In May 2021, Japan-based packaging company Nipro PharmaPackaging had acquired Croatian glass pharmaceutical packaging manufacturer Piramida. Under the ownership of Blue Sea Capital private equity fund, Piramida got a modernisation of its facilities, welcomed eight new production lines, and witnessed a strong development of its ampoules and vials business. This led the company being ranked among the top five largest ampoule manufacturers for the pharmaceutical industry in the European market.
In March 2021, Aenova, one of the leading development service provider sand contract manufacturers for the pharmaceutical and healthcare industries, significantly increased its ampoule capacities, at its Gronau site. With the new ampoule filling and closing line, the sixth sterile line at the Gronau site, a new fully automatic optical control line and a likewise new packaging line, a total of more than 100 million ampoules and vials can now be produced per year.
Material Types Covered:
Capacities Covered:
Ampoule Types Covered:
Applications Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa Regions are also represented in the same manner as above.